Single-Use Technologies for Biopharmaceuticals: Global Markets

Report Highlights

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

Report Includes

• An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters.
• Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
• In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges.
• Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs.
• Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares.
• Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns.
• Relevant patent analysis.

Report Scope

The scope of this report includes the single-use technologies used in the bioprocessing industry. These are single-use bioreactors, membrane adsorbers, media bags, tubing and connectors, bioprocess containers, disposable mixing systems, samplers, filter cartridges, depth filtration system, tangential flow filtration system and other single-use products such as valves, clamps, etc.

The report covers market application areas such as monoclonal antibodies (mAbs), vaccines, gene therapy, recombinant proteins, blood derivatives and anti-cancer drugs, and the market by end users, which include contract manufacturing organizations and biopharmaceutical manufacturers. Excluded from this report are control software and the custom-designed software used with single-use biopharmaceutical manufacturing technologies.

BCC Research analyzes each market from a global scope and its application, regulatory environment, technologies involved, market projections and market shares. The emerging market covers countries like India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, Canada, etc.

Key restraints include leachables and extractables, cost constraints and breakage of bags. The report includes relevant patent analysis and comprehensive profiles of companies that lead the single-use technology market, such as EMD Millipore, GE Healthcare, Pall Corp., Sartorius Stedim Biotech and Thermo Fisher Scientific, among others.

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.